Aurinia Pharmaceuticals Inc (AUPH)
9.03
-0.01
(-0.11%)
USD |
NASDAQ |
Dec 20, 16:00
9.035
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Shareholders Equity (Quarterly): 388.00M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Edesa Biotech Inc | 1.981M |
| Lexaria Bioscience Corp | 8.036M |
| Xenon Pharmaceuticals Inc | 797.81M |
| ESSA Pharma Inc | 124.61M |
| ImmunoPrecise Antibodies Ltd | 23.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 549.36M |
| Total Liabilities (Quarterly) | 161.36M |
| Current Ratio | 5.603 |